InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by FAMBROUGH DOUGLAS, Chairman & CEO. Insider active across 1 company, notably Dicerna Pharmaceuticals Inc. Cumulatively, 8 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €188k. History available since 10 August 2021. The latest transaction was disclosed on 28 December 2021 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
231,431 shares@ US$38.2548.9% of flowCommon StockSEC:0001399529-21-000198
231,431 shares@ US$38.2548.9% of flowCommon StockSEC:0001399529-21-000198:0
13,750 sharesCommon StockSEC:0001399529-21-000174
13,750 sharesCommon StockSEC:0001399529-21-000174:0
33,670 shares@ US$2.970.6% of flowCommon StockSEC:0001399529-21-000162
33,670 shares@ US$2.970.6% of flowCommon StockSEC:0001399529-21-000162:0
5,000 shares@ US$22.0960.6% of flowCommon StockSEC:0001399529-21-000146:0
Ideal exit: 7 May 2022 (T+270)
5,000 shares@ US$22.0960.6% of flowCommon StockSEC:0001399529-21-000146
Ideal exit: 7 May 2022 (T+270)
8 of 8 declarations
About FAMBROUGH DOUGLAS
Douglas Fambrough is President and CEO of Dicerna Pharmaceuticals Inc. He leads the company with a focus on innovation and the development of new therapies. His leadership is pivotal to Dicerna's mission.
